Key facts
- This page summarizes Douglas E. Williams's Form 3 filing for Climb Bio, Inc. (CLYM).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 12 Nov 2024, 17:33.
Douglas E. Williams - 08 Nov 2024 Form 3 Insider Report for Climb Bio, Inc. (CLYM)
- Reporting relationship
- Director
- Issuer ticker
- CLYM
- Reported as of
- 08 Nov 2024
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 12 Nov 2024, 17:33:07 UTC
- Prior SEC filing
- 08 Mar 2024
- Next SEC filing
- 12 Nov 2024
- Source filing
- View source filing
- Reporting owner signature
- Emily Pimblett, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Douglas E. Williams filed Form 3 for Climb Bio, Inc. (CLYM) on 12 Nov 2024.
Change
- Previous filing in this sequence was filed on 08 Mar 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Additional SEC filing notes
Filing notes and footnotes
Ownership status
The filing reports no beneficially owned securities.
SEC remarks
Exhibit Index: 24.1 - Power of Attorney